Bide Pharmatech Co

Bide Pharmatech Co EBIT per Share

The EBIT per Share of Bide Pharmatech Co (688073.SS) as of Oct 12, 2026 is 2.66 CNY. In the previous year, EBIT per Share was 1.75 CNY — a change of 52.34% (higher).

EBIT per Share

2.66CNY

YoY

52.34%

Last updated:

EBIT per Share of Bide Pharmatech Co is 2025 2.66 CNY. EBIT per Share of Bide Pharmatech Co was 2024 1.75 CNY. It decreases by 52.34% higher compared to the previous year.

The Bide Pharmatech Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
1.01 CNY
Jan 1, 2021
1.37 CNY
Jan 1, 2022
1.83 CNY
Jan 1, 2023
1.42 CNY
Jan 1, 2024
1.75 CNY
Jan 1, 2025
2.66 CNY
Jan 1, 2026 (e)
0.00 CNY
Jan 1, 2027 (e)
0.00 CNY
The Bide Pharmatech Co EBIT per Share history
YEAREBIT per ShareYoY
est0.00CNY—
est0.00CNY-100.00%
2.66CNY+52.34%
1.75CNY+23.19%
1.42CNY-22.52%
1.83CNY+33.97%
1.37CNY+35.65%
1.01CNY+965.45%
0.09CNY—
Access this data via the Eulerpool API
Get Free API Key

Bide Pharmatech Co Stock analysis

What does Bide Pharmatech Co do? Bide Pharmatech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bide Pharmatech Co stock

EBIT per Share of Bide Pharmatech Co is 2.66 CNY in 2025.

EBIT per Share of Bide Pharmatech Co changed from 1.75 CNY to 2.66 CNY, representing a 52.34% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Bide Pharmatech Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Bide Pharmatech Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Bide Pharmatech Co